Cargando…

What is the impact of age on adult patients with inflammatory bowel disease?

Inflammatory bowel disease (IBD) is a chronic disease that affects both young adults and also the elderly. This article emphasises the particularities related to age in the epidemiology, diagnosis, natural course of the disease, prognosis and therapy of adult patients with IBD. Even though the main...

Descripción completa

Detalles Bibliográficos
Autores principales:	PRELIPCEAN, CRISTINA CIJEVSCHI, MIHAI, CĂTĂLINA, GOGALNICEANU, PETRUŢ, MIHAI, BOGDAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2013
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462481/ https://www.ncbi.nlm.nih.gov/pubmed/26527906

Ejemplares similares

Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention
por: Jucan, Alina Ecaterina, et al.
Publicado: (2022)

COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges
por: Popa, Iolanda Valentina, et al.
Publicado: (2020)

Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
por: Jucan, Alina Ecaterina, et al.
Publicado: (2023)

Anemia in Crohn’s Disease—The Unseen Face of Inflammatory Bowel Disease
por: Dranga, Mihaela, et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
por: Gavrilescu, Otilia, et al.
Publicado: (2022)

Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients
por: Mihai, Bogdan Mircea, et al.
Publicado: (2018)

A Machine Learning Model Accurately Predicts Ulcerative Colitis Activity at One Year in Patients Treated with Anti-Tumour Necrosis Factor α Agents
por: Popa, Iolanda Valentina, et al.
Publicado: (2020)

Laboratory Data and IBDQ—Effective Predictors for the Non-Invasive Machine-Learning-Based Prediction of Endoscopic Activity in Ulcerative Colitis
por: Gavrilescu, Otilia, et al.
Publicado: (2023)

The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management
por: Vulpoi, Radu Alexandru, et al.
Publicado: (2023)

Extrapancreatic necrosis volume: A new tool in acute pancreatitis severity assessment?
por: Cucuteanu, Bogdan, et al.
Publicado: (2021)

New onset severe ulcerative colitis following Ixekizumab therapy
por: Morosanu, Alina Mihaela, et al.
Publicado: (2022)

Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!
por: Cozma-Petruţ, Anamaria, et al.
Publicado: (2017)

Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response
por: Gavril, Oana Irina, et al.
Publicado: (2021)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

The Intertwining Roads between Psychological Distress and Gut Microbiota in Inflammatory Bowel Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
por: Pavel, Flavia Maria, et al.
Publicado: (2021)

We Asked the Experts: Delivering Resilient Surgical Care in a Crisis—Five Survival Strategies for Front-Line Surgeons
por: Gogalniceanu, Petrut, et al.
Publicado: (2020)

Capturing the crisis ‘golden moment’ – A leadership opportunity for overcoming institutional inertia in safety-critical situations
por: Gogalniceanu, Petrut, et al.
Publicado: (2021)

Thrombosis in inflammatory bowel diseases: what’s the link?
por: Giannotta, Martina, et al.
Publicado: (2015)

Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania
por: Goldiș, Adrian, et al.
Publicado: (2019)

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
por: Cazac, Georgiana-Diana, et al.
Publicado: (2022)

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes
por: Cazac, Georgiana-Diana, et al.
Publicado: (2022)

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
por: Trifan, Anca, et al.
Publicado: (2017)

The Prevalence and Association of Cognitive Impairment with Sleep Disturbances in Patients with Chronic Liver Disease
por: Plotogea, Oana-Mihaela, et al.
Publicado: (2022)

What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
por: Park, Su Bee, et al.
Publicado: (2022)

Endovascular intervention in the maintenance and rescue of paediatric arteriovenous fistulae for hemodialysis
por: Gogalniceanu, Petrut, et al.
Publicado: (2018)

Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?
por: Kim, Jeongseok, et al.
Publicado: (2019)

Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?
por: Kim, Jeongseok, et al.
Publicado: (2019)

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives
por: Cazac, Georgiana-Diana, et al.
Publicado: (2023)

Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
por: Shafiee, Nor Hamizah, et al.
Publicado: (2021)

What's app? Electronic health technology in inflammatory bowel disease
por: Walsh, Alissa, et al.
Publicado: (2018)

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?
por: Solitano, Virginia, et al.
Publicado: (2021)

Inflammatory bowel disease in Africa: what is the current state of knowledge?
por: Hodges, Phoebe, et al.
Publicado: (2020)

Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2017)

What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?
por: Barbalho, Sandra Maria, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?
por: Fousekis, Fotios S., et al.
Publicado: (2021)

What Should I Eat? Dietary Recommendations for Patients with Inflammatory Bowel Disease
por: Saha, Srishti, et al.
Publicado: (2023)

Liver involvement in inflammatory bowel disease: What should the clinician know?
por: Losurdo, Giuseppe, et al.
Publicado: (2021)

Clinical significance of tumor necrosis factor-alpha and carcinoembryonic antigen in gastric cancer
por: Roșu, Mihai Cătălin, et al.
Publicado: (2022)

What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_en1rhsjmadqpbgdgvcjcnq4php